[go: up one dir, main page]

DK0700397T3 - Hidtil ukendte thiazolidindioner og lægemidler, der indeholder disse - Google Patents

Hidtil ukendte thiazolidindioner og lægemidler, der indeholder disse

Info

Publication number
DK0700397T3
DK0700397T3 DK94918342T DK94918342T DK0700397T3 DK 0700397 T3 DK0700397 T3 DK 0700397T3 DK 94918342 T DK94918342 T DK 94918342T DK 94918342 T DK94918342 T DK 94918342T DK 0700397 T3 DK0700397 T3 DK 0700397T3
Authority
DK
Denmark
Prior art keywords
denotes
pct
alkyl
heteroatoms
sec
Prior art date
Application number
DK94918342T
Other languages
English (en)
Inventor
Hans-Peter Wolff
Peter Freund
Alfred Mertens
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK0700397T3 publication Critical patent/DK0700397T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94918342T 1993-05-25 1994-05-19 Hidtil ukendte thiazolidindioner og lægemidler, der indeholder disse DK0700397T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4317320A DE4317320A1 (de) 1993-05-25 1993-05-25 Neue Thiazolidindione und diese enthaltende Arzneimittel
PCT/EP1994/001619 WO1994027995A1 (de) 1993-05-25 1994-05-19 Neue thiazolidindione und diese enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DK0700397T3 true DK0700397T3 (da) 2003-01-06

Family

ID=6488833

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918342T DK0700397T3 (da) 1993-05-25 1994-05-19 Hidtil ukendte thiazolidindioner og lægemidler, der indeholder disse

Country Status (25)

Country Link
US (1) US5599826A (da)
EP (1) EP0700397B1 (da)
JP (1) JP3162721B2 (da)
KR (1) KR100243783B1 (da)
CN (1) CN1040324C (da)
AT (1) ATE223409T1 (da)
AU (1) AU682699B2 (da)
CA (1) CA2163028C (da)
CL (1) CL2004001167A1 (da)
CY (1) CY2415B1 (da)
CZ (1) CZ285927B6 (da)
DE (2) DE4317320A1 (da)
DK (1) DK0700397T3 (da)
ES (1) ES2180581T3 (da)
FI (1) FI955685A0 (da)
HU (1) HU217065B (da)
NO (1) NO307832B1 (da)
NZ (1) NZ267410A (da)
PL (1) PL180046B1 (da)
PT (1) PT700397E (da)
RO (1) RO114328B1 (da)
RU (1) RU2122002C1 (da)
SK (1) SK282618B6 (da)
UA (1) UA41362C2 (da)
WO (1) WO1994027995A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138258A (ja) * 1993-11-16 1995-05-30 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
ATE236154T1 (de) * 1995-07-31 2003-04-15 Shionogi & Co Pyrrolydin-derivate mit einer phospholipase a2 inhibierenden wirkung
JPH09176162A (ja) * 1995-12-22 1997-07-08 Toubishi Yakuhin Kogyo Kk チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
DE19619819A1 (de) * 1996-05-16 1997-11-20 Boehringer Mannheim Gmbh Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltenden Arzneimittel
DE19711617A1 (de) * 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE19711616A1 (de) * 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Verbessertes Verfahren zur Herstellung von Thiazolidindionen
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
WO2000030628A2 (en) * 1998-11-20 2000-06-02 Genentech, Inc. Method of inhibiting angiogenesis
DE60026404T2 (de) 1999-08-02 2006-10-19 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von Benzothiophen-Derivaten
US6531609B2 (en) 2000-04-14 2003-03-11 Hoffmann-La Roche Inc. Process for the preparation of thiazolidinedione derivatives
AU6591401A (en) * 2000-05-08 2001-11-20 Hoffmann La Roche Para-amine substituted phenylamide glucokinase activators
CN1236764C (zh) 2000-06-27 2006-01-18 霍夫曼-拉罗奇有限公司 制备组合物的方法
EP1726586A1 (en) * 2000-12-25 2006-11-29 Ono Pharmaceutical Co., Ltd. Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
US7323481B2 (en) 2001-04-06 2008-01-29 Hoffmann-La Roche Inc. Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
PT1392295E (pt) 2001-05-15 2006-09-29 Hoffmann La Roche Derivados de oxazole substituidos por acidos carboxilicos para serem utilizados como activadores de rapp alfa e gama no tratamento de diabetes
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd 5−[6−(2−フルオロベンジルオキシ)−2−ナフチル]メチル−2,4−チアゾリジンジオンの製造方法及びその精製方法
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
ES2291688T3 (es) * 2002-07-03 2008-03-01 F. Hoffmann-La Roche Ag Derivados de oxazol y su empleo como sensibilizadores a la insulina.
PL375779A1 (en) * 2002-08-30 2005-12-12 F.Hoffmann-La Roche Ag Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
DE60309719T2 (de) * 2002-09-12 2007-09-20 F. Hoffmann-La Roche Ag N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis
EP1567523B1 (en) * 2002-11-25 2008-08-20 F.Hoffmann-La Roche Ag Indolyl derivatives
WO2005000844A1 (en) 2003-06-26 2005-01-06 F. Hoffmann-La Roche Ag Process for the preparation of insulin sensitizer and intermediate compound thereof
CN101693202B (zh) * 2009-10-21 2011-04-20 沧州那瑞化学科技有限公司 盐酸吡咯列酮关键中间体加氢反应催化剂及加氢反应方法
US20150004144A1 (en) 2011-12-02 2015-01-01 The General Hospital Corporation Differentiation into brown adipocytes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
WO1986007056A1 (en) * 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
GB8713861D0 (en) * 1987-06-13 1987-07-15 Beecham Group Plc Compounds
WO1989008052A1 (en) * 1988-03-04 1989-09-08 Kurt H. Volk, Incorporated Direct mail article with mailable reply card
WO1989008652A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
EP0533933A4 (en) * 1990-07-03 1993-05-05 Yamanouchi Pharmaceutical Co. Ltd. Bisheterocyclic compound
FR2688220A1 (fr) * 1992-03-06 1993-09-10 Adir Nouveaux derives de thiazolidine-2,4-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DE59410181D1 (de) 2002-10-10
HU217065B (hu) 1999-11-29
KR960702460A (ko) 1996-04-27
RO114328B1 (ro) 1999-03-30
HU9503376D0 (en) 1996-01-29
JPH08510456A (ja) 1996-11-05
FI955685L (fi) 1995-11-24
SK282618B6 (sk) 2002-10-08
PT700397E (pt) 2002-12-31
AU6970494A (en) 1994-12-20
CZ299995A3 (en) 1996-03-13
SK146195A3 (en) 1996-06-05
CN1124488A (zh) 1996-06-12
NZ267410A (en) 1996-12-20
JP3162721B2 (ja) 2001-05-08
PL311752A1 (en) 1996-03-18
ES2180581T3 (es) 2003-02-16
NO954762D0 (no) 1995-11-24
NO307832B1 (no) 2000-06-05
US5599826A (en) 1997-02-04
ATE223409T1 (de) 2002-09-15
AU682699B2 (en) 1997-10-16
WO1994027995A1 (de) 1994-12-08
EP0700397B1 (de) 2002-09-04
CZ285927B6 (cs) 1999-11-17
CY2415B1 (en) 2004-11-12
DE4317320A1 (de) 1994-12-01
CA2163028C (en) 2003-11-25
PL180046B1 (en) 2000-12-29
CL2004001167A1 (es) 2005-05-20
CN1040324C (zh) 1998-10-21
RU2122002C1 (ru) 1998-11-20
UA41362C2 (uk) 2001-09-17
EP0700397A1 (de) 1996-03-13
CA2163028A1 (en) 1994-12-08
FI955685A0 (fi) 1995-11-24
NO954762L (no) 1995-11-24
HUT75099A (en) 1997-04-28
KR100243783B1 (ko) 2000-03-02

Similar Documents

Publication Publication Date Title
DK0700397T3 (da) Hidtil ukendte thiazolidindioner og lægemidler, der indeholder disse
NO952129L (no) Oksalylamino-benzofuran- og benzotienyl-derivater
NO20013379D0 (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
WO2007125321A3 (en) Purine and deazapurine derivatives as pharmaceutical compounds
HUP0104693A2 (hu) Eljárás az ízületi gyulladás MEK inhibitorokkal való kezelésére
RU92016545A (ru) Гетероциклические соединения, способ их получения и фармацевтическая композиция
GB9300195D0 (en) Piperazine derivatives
RU2005100761A (ru) Амидзамещенные производные ксантина, обладающие модуляторной активностью в отношении биосинтеза глюкозы из неуглеводных субстратов
LV11832A (lv) O-acil-4-fenilcikloheksanoli to salis zalu lidzekli kas satur minetas vielas un to pielietojums
HU911992D0 (en) 2-(amino-alkyl)-5-(aryl-alkyl)-1,3-dioxanes, and process for the production of the medical preparations containing them
KR890009867A (ko) 비 펩타이드성 레닌 억제제
NO933477D0 (no) 6-heterosyklisk-4-amino-1,3,4,5-tetrahydrobenz(cd)indolerfor behandling av reisesyke og oppkast
DE69910083D1 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
SE9702534D0 (sv) Compounds
ZA831477B (en) Substituted pyridines,processes for preparing these and pharmaceutical composition thereof
SU1593568A3 (ru) Cпocoб пoлучehия пpoизboдhыx 4-(4-aлkилфehил)-tиaзoл-2-илa
NO159018C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive disubstituerte polymetyleniminer.
MX9305918A (es) Derivados de n-(2-amino-2-oxoetil)butanodiamida inhibidores de la renina procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES466555A1 (es) Procedimiento para la preparacion de nuevos 2,5-dihidro-1,2-tiazino (5,6-b)indol-3-carboxamido-1,1-dioxidos.
KR880012587A (ko) 치환된 퀴녹살릴-이미다졸리딘-2,4-디온, 이의 제조 방법, 및 약제 및 약제학적 제제로서의 이의 용도
BR9812928A (pt) Novos derivados de 3-oxo-(2h) -1,2,4-triazina, processo de preparação de compostos quìmicos, e, composição farmacêutica
ATE167873T1 (de) Neue heterocyclische acyldipeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung